Cargando…
Corrigendum: Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707332/ https://www.ncbi.nlm.nih.gov/pubmed/36458042 http://dx.doi.org/10.3389/fnins.2022.1085572 |
| _version_ | 1784840692609056768 |
|---|---|
| author | Rahimlou, Mehran Nematollahi, Shima Husain, Durdana Banaei-Jahromi, Nasrin Majdinasab, Nastaran Hosseini, Seyed Ahmad |
| author_facet | Rahimlou, Mehran Nematollahi, Shima Husain, Durdana Banaei-Jahromi, Nasrin Majdinasab, Nastaran Hosseini, Seyed Ahmad |
| author_sort | Rahimlou, Mehran |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9707332 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97073322022-11-30 Corrigendum: Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial Rahimlou, Mehran Nematollahi, Shima Husain, Durdana Banaei-Jahromi, Nasrin Majdinasab, Nastaran Hosseini, Seyed Ahmad Front Neurosci Neuroscience Frontiers Media S.A. 2022-11-15 /pmc/articles/PMC9707332/ /pubmed/36458042 http://dx.doi.org/10.3389/fnins.2022.1085572 Text en Copyright © 2022 Rahimlou, Nematollahi, Husain, Banaei-Jahromi, Majdinasab and Hosseini. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Neuroscience Rahimlou, Mehran Nematollahi, Shima Husain, Durdana Banaei-Jahromi, Nasrin Majdinasab, Nastaran Hosseini, Seyed Ahmad Corrigendum: Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial |
| title | Corrigendum: Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial |
| title_full | Corrigendum: Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial |
| title_fullStr | Corrigendum: Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial |
| title_full_unstemmed | Corrigendum: Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial |
| title_short | Corrigendum: Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial |
| title_sort | corrigendum: probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: a randomized, double-blind, placebo-controlled trial |
| topic | Neuroscience |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707332/ https://www.ncbi.nlm.nih.gov/pubmed/36458042 http://dx.doi.org/10.3389/fnins.2022.1085572 |
| work_keys_str_mv | AT rahimloumehran corrigendumprobioticsupplementationandsystemicinflammationinrelapsingremittingmultiplesclerosisarandomizeddoubleblindplacebocontrolledtrial AT nematollahishima corrigendumprobioticsupplementationandsystemicinflammationinrelapsingremittingmultiplesclerosisarandomizeddoubleblindplacebocontrolledtrial AT husaindurdana corrigendumprobioticsupplementationandsystemicinflammationinrelapsingremittingmultiplesclerosisarandomizeddoubleblindplacebocontrolledtrial AT banaeijahrominasrin corrigendumprobioticsupplementationandsystemicinflammationinrelapsingremittingmultiplesclerosisarandomizeddoubleblindplacebocontrolledtrial AT majdinasabnastaran corrigendumprobioticsupplementationandsystemicinflammationinrelapsingremittingmultiplesclerosisarandomizeddoubleblindplacebocontrolledtrial AT hosseiniseyedahmad corrigendumprobioticsupplementationandsystemicinflammationinrelapsingremittingmultiplesclerosisarandomizeddoubleblindplacebocontrolledtrial |